comparemela.com

Robert Pyo News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Vivasure Medical Announces First Patient Treated in U S Early Feasibility Study Evaluating PerQseal+

Study is the first in the U.S. to evaluate the company’s fully absorbable, patch-based percutaneous closure device for large-bore vessels in transcatheter aortic valve replacement

New yorkUnited statesStony brookRobert pyoWilliam grayLankenau heart instituteMain line healthStony brook university hospital inVivasure medicalStony brook university hospitalAndrew glassPerqseal blue

Vivasure treats first patient in U S study for next-gen PerQseal+ in TAVR procedures

Vivasure Medical announced that the first patient was treated in a U.S. early feasibility study of its next-generation PerQseal+ device.

New yorkUnited statesVivasure medicalIreland based vivasureRobert pyoStony brook university hospitalStony brookPerqseal blue

vimarsana © 2020. All Rights Reserved.